These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25639689)

  • 1. Serum brain-derived neurotropic factor level predicts adverse clinical outcomes in patients with heart failure.
    Fukushima A; Kinugawa S; Homma T; Masaki Y; Furihata T; Yokota T; Matsushima S; Takada S; Kadoguchi T; Oba K; Okita K; Tsutsui H
    J Card Fail; 2015 Apr; 21(4):300-6. PubMed ID: 25639689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure.
    Shibata A; Hanatani A; Izumi Y; Kitada R; Iwata S; Yoshiyama M
    Heart Vessels; 2018 Nov; 33(11):1325-1333. PubMed ID: 29700574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.
    Kadowaki S; Shishido T; Honda Y; Narumi T; Otaki Y; Kinoshita D; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kubota I
    Heart Vessels; 2016 Apr; 31(4):535-44. PubMed ID: 25616498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure.
    Takashio S; Sugiyama S; Yamamuro M; Takahama H; Hayashi T; Sugano Y; Izumiya Y; Hokimoto S; Minamino N; Yasuda S; Anzai T; Ogawa H
    Am J Cardiol; 2015 Jul; 116(2):243-9. PubMed ID: 25983281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction.
    Barman HA; Şahin I; Atıcı A; Durmaz E; Yurtseven E; Ikitimur B; Okuyan E; Keleş I
    Anatol J Cardiol; 2019 Nov; 22(6):309-316. PubMed ID: 31789613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy.
    Costa HS; Lima MMO; Figueiredo PHS; Martinelli PM; Camargos ER; Chaves AT; Nunes MCP; Rocha MOC
    Mem Inst Oswaldo Cruz; 2018 Aug; 113(10):e180224. PubMed ID: 30133549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of step counts to predict mortality in Japanese patients with heart failure.
    Izawa KP; Watanabe S; Oka K; Hiraki K; Morio Y; Kasahara Y; Brubaker PH; Osada N; Omiya K; Shimizu H
    Am J Cardiol; 2013 Jun; 111(12):1767-71. PubMed ID: 23540653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Brain-Derived Neurotrophic Factor Levels Are Associated with Skeletal Muscle Function but Not with Muscle Mass in Patients with Heart Failure.
    Nakano I; Kinugawa S; Hori H; Fukushima A; Yokota T; Takada S; Kakutani N; Obata Y; Yamanashi K; Anzai T
    Int Heart J; 2020 Jan; 61(1):96-102. PubMed ID: 31956152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of indeterminable anaerobic threshold in heart failure.
    Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
    Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
    Guazzi M; Boracchi P; Labate V; Arena R; Reina G
    J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value.
    Guazzi M; Arena R; Ascione A; Piepoli M; Guazzi MD;
    Am Heart J; 2007 May; 153(5):859-67. PubMed ID: 17452165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
    Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L
    Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.
    Arena R; Myers J; Aslam SS; Varughese EB; Peberdy MA
    Am Heart J; 2004 Feb; 147(2):354-60. PubMed ID: 14760336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
    Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY; Metra M; Thabut G; Logeart D; Cohen-Solal A
    Am J Cardiol; 2006 Aug; 98(4):500-3. PubMed ID: 16893705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of heart rate recovery in patients with heart failure.
    Arena R; Guazzi M; Myers J; Peberdy MA
    Am Heart J; 2006 Apr; 151(4):851.e7-13. PubMed ID: 16569547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of resting end-tidal carbon dioxide in patients with heart failure.
    Arena R; Peberdy MA; Myers J; Guazzi M; Tevald M
    Int J Cardiol; 2006 May; 109(3):351-8. PubMed ID: 16046017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments.
    Corrà U; Giordano A; Mezzani A; Gnemmi M; Pistono M; Caruso R; Giannuzzi P
    Eur J Prev Cardiol; 2012 Feb; 19(1):32-40. PubMed ID: 21450614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.